These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8950136

  • 21. Susceptibility of spontaneously hypertensive rats to the diabetogenic effects of streptozotocin.
    Jian K, Fok E, Cam MC, Sambandam N, Yao J, Rodrigues B.
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1215-21. PubMed ID: 9028580
    [Abstract] [Full Text] [Related]

  • 22. Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats.
    Liu IM, Chen WC, Cheng JT.
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1196-204. PubMed ID: 12975496
    [Abstract] [Full Text] [Related]

  • 23. Renal sympathetic nerve discharge mediated by the paraventricular nucleus is altered in STZ induced diabetic rats.
    Reynolds AY, Zhang K, Patel KP.
    Nebr Med J; 1996 Dec; 81(12):419-23. PubMed ID: 9046793
    [Abstract] [Full Text] [Related]

  • 24. Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy.
    Van Linthout S, Spillmann F, Riad A, Trimpert C, Lievens J, Meloni M, Escher F, Filenberg E, Demir O, Li J, Shakibaei M, Schimke I, Staudt A, Felix SB, Schultheiss HP, De Geest B, Tschöpe C.
    Circulation; 2008 Mar 25; 117(12):1563-73. PubMed ID: 18332268
    [Abstract] [Full Text] [Related]

  • 25. Changes in electrophysiological and mechanical responses of the rat papillary muscle to alpha- and beta-agonist in streptozotocin-induced diabetes.
    Kamata K, Satoh T, Tanaka H, Shigenobu K.
    Can J Physiol Pharmacol; 1997 Jul 25; 75(7):781-8. PubMed ID: 9315344
    [Abstract] [Full Text] [Related]

  • 26. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
    Hakim ZS, Goyal RK.
    Indian J Physiol Pharmacol; 2000 Apr 25; 44(2):125-35. PubMed ID: 10846625
    [Abstract] [Full Text] [Related]

  • 27. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation.
    Patki KC, Joglekar SJ, Kamat SK, Thatte UM, Yeolekar ME, Rege NN, Dahanukar SA, Nanivadekar AS.
    J Assoc Physicians India; 1998 Apr 25; Suppl 1():26-9. PubMed ID: 11229106
    [Abstract] [Full Text] [Related]

  • 28. Oral magnesium administration prevents vascular complications in STZ-diabetic rats.
    Soltani N, Keshavarz M, Sohanaki H, Dehpour AR, Zahedi Asl S.
    Life Sci; 2005 Feb 11; 76(13):1455-64. PubMed ID: 15680310
    [Abstract] [Full Text] [Related]

  • 29. [The indices of systemic and regional hemodynamics in waking rats with streptozotocin diabetes].
    Medvedeva NA, Kuznetsova LV, Medvedev OS.
    Fiziol Zh (1978); 1992 Feb 11; 38(2):25-9. PubMed ID: 1568492
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts].
    Song XD, Chen CZ, Dong B, Shi YY, Zhang W, Yan LS, Luo GA.
    Zhonghua Yan Ke Za Zhi; 2003 Oct 11; 39(10):605-9. PubMed ID: 14766075
    [Abstract] [Full Text] [Related]

  • 32. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chan P, Liu IM, Tzeng TF, Yang TL, Cheng JT.
    Diabetes Obes Metab; 2007 Jan 11; 9(1):39-49. PubMed ID: 17199717
    [Abstract] [Full Text] [Related]

  • 33. Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chi TC, Ho YJ, Chen WP, Chi TL, Lee SS, Cheng JT, Su MJ.
    Life Sci; 2007 Apr 24; 80(20):1832-8. PubMed ID: 17397876
    [Abstract] [Full Text] [Related]

  • 34. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J, Stivrina M, Stoldere Dz, Vigante B, Duburs G.
    Cell Biochem Funct; 2007 Apr 24; 25(6):673-80. PubMed ID: 16986170
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.
    Rouyer O, Zoll J, Daussin F, Damgé C, Helms P, Talha S, Rasseneur L, Piquard F, Geny B.
    Exp Physiol; 2007 Nov 24; 92(6):1047-56. PubMed ID: 17675412
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model.
    Palm F, Ortsäter H, Hansell P, Liss P, Carlsson PO.
    Diabetes Metab Res Rev; 2004 Nov 24; 20(6):452-9. PubMed ID: 15386825
    [Abstract] [Full Text] [Related]

  • 39. The effect of long-term supplementation of vitamin C on pulpal blood flow in streptozotocin-induced diabetic rats.
    Amatyakul S, Chakraphan D, Chotpaibulpan S, Patumraj S.
    Clin Hemorheol Microcirc; 2003 Nov 24; 29(3-4):313-9. PubMed ID: 14724356
    [Abstract] [Full Text] [Related]

  • 40. Forearm and finger hemodynamics, blood pressure control, and lipid changes in patients with diabetic hypertension treated with atenolol and prazosin.
    Kwan CM, Shepherd AM, Johnson J, Taylor WF.
    Clin Pharmacol Ther; 1988 Aug 24; 44(2):202-10. PubMed ID: 3293875
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.